Hyaluronic acid and wound healing

Wound Repair and Regeneration

Volumn 20, Issue 3, 2012, Pages 317-331

  Voigt, Jeffrey ^a   Driver, Vickie R ^b  

^a Medical Device Consultants of Ridgewood LLC   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONECTTIVINA PLUS; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; PLACEBO; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

AUTOGRAFT; BURN; CELL PROLIFERATION; CHRONIC VEIN INSUFFICIENCY; CHRONIC WOUND; COMPRESSION BANDAGE; CREAM; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC PATIENT; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FOOT ULCER; GEL; HUMAN; IRRADIATION; KERATINOCYTE; META ANALYSIS; NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; SKIN GRAFT; SKIN SURGERY; SURGICAL WOUND; SYSTEMATIC REVIEW; TATTOO; TISSUE ENGINEERING; TISSUE GRAFT; TREATMENT OUTCOME; ULCER HEALING; WOUND DRESSING; WOUND HEALING; CHRONIC DISEASE; DRUG EFFECT; FEMALE; MALE;

BURNS; CHRONIC DISEASE; DIABETIC FOOT; FEMALE; HUMANS; HYALURONIC ACID; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WOUND HEALING;

EID: 84860606545     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00777.x     Document Type: Review

References (50)

1. Altman RD, Moskowtiz R,. Intraarticular sodium hyaluronate (Hyalogan) in the treatment of patients with osteoarthritis of the knee: a randomized controlled trial. Hyalogan Study Group. J Rheumatol 1998; 25: 2203-2212. (Pubitemid 28505869)
2. Bellamy N, Campbell J, Welch V, Gee TL, Bourne R, Wells GA,. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006; (2): CD005328. DOI: 10.1102/14651858.CD005328. pub.2.
3. Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU,. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis-a prospective clinical trial. Osteoarthritis Cartilage 2001; 10: 680-686.
4. Brooks DR, Conaghan PG, Petersen M,. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004; 31: 775-782. (Pubitemid 38451267)
5. Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA,. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 2006; 88: 295-302. (Pubitemid 43185130)
6. Westrich G, Schaefer S, Walcott-Sapp S, Lyman S,. Randomized prospective evaluation of adjuvant hyaluronic acid therapy administered after knee arthroscopy. Am J Orthop 2009; 38: 612-616.
7. Chou WY, Ko JY, Wang FS, Huang CC, Wong T, Wang CJ, Chang HE,. Effect of sodium hyaluronate treatment on rotator cuff lesions without complete tears: a randomized, double-blind, placebo-controlled study. J Shoulder Elbow Surg 2010; 19: 557-563.
8. Kumar S, Wong PF, Leaper DJ,. Intra-peritoneal prophylaxis agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev 2009; (1): CD005080. DOI: 10.1002/14651858.CD005080.pub.2.
9. Gill D,. Angiogenic modulation. J Wound Care 1998; 7: 411-414.
10. Bourguignon LYW, Ramez M, Gilad E, Singleton PA, Man MQ, Crumrine DA, Elias PM, Feingold KR,. Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostatis. J Invest Dermatol 2006; 126: 1356-1365. (Pubitemid 43997919)
11. Culp LA, Murray BA, Rollins BJ,. Firbronectin and proteoglycan as determinants of cell-substratum adhesion. J Supramol Struct 1979; 11: 401-427. (Pubitemid 10069150)
12. King SR, Hickerson WL, Proctor KG, Newsome AM,. Beneficial actions of exogenous hyaluronic acid in wound healing. Surgery 1991; 109: 76-84.
13. Calvin M,. Cutaneous wound repair. Wounds 1998; 10: 12-32.
14. Higgins JPT, Green D, editors. Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2010]. The Cochrane Collaboration 2011. Available at (accessed November 25, 2011).
15. Ortonne JP,. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat 1996; 7: 75-81. (Pubitemid 26235527)
16. Mekkes JR, Nahuys M,. Induction of granulation tissue formation in chronic wounds by hyaluronic acid. Wounds 2001; 13: 159-164.
17. Bettinger DA, Mast B, Gore D,. Hyaluronic acid impedes reepithelialization of skin graft donor sites. J Burn Care Rehabil 1996; 17: 302-304. (Pubitemid 26286638)
18. Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J,. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997; 42: 155-161. (Pubitemid 27132744)
19. Costagliola M, Agrosi M,. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone. Curr Med Res Opin 2005; 21: 1235-1240. (Pubitemid 41140727)
20. Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A,. HYAFF-11 based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot Ulcers. Diabetes Care 2003; 26: 2853-2859.
21. Uccioli L, Giurato L, Ruotolo V, Civaarella A, Grimaldi MS, Piaggesi A, Teobaldi I, Ricci L, Scionti L, Vermigli C, Seguro R, Mancini L, Ghirlanda G,. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled trial with long-term follow-up. Int J Low Extrem Wounds 2011; 10: 80-85.
22. Vazquez JR, Short B, Findlow AH, Nixon BP, Boulton JM, Armstrong DG,. Outcomes of hyaluronan therapy in diabetic foot wounds. Diabetes Res Clin Pract 2003; 59: 123-127. (Pubitemid 36135830)
23. Edmonds M, Foster A,. Hyalofill: a new product for chronic wound management. Diabet Foot 2000; 3: 29-30.
24. Abbruzzese L, Rizzo L, Fanelli G, Tedeschi A, Scatena A, Goretti C, Macchiarini S, Piaggesi A,. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial. Int J Low Extrem Wounds 2009; 8: 134-140.
25. Price RD, Das-Gupta V, Leigh IM, Navasria HA,. A comparison of tissue-engineered hyaluronic acid dermal matrices in a human wound model. Tissue Eng 2006; 12: 2985-2995. (Pubitemid 46141263)
26. Nolan A, Badminton J, Maguire J, Seymour RA,. The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med 2009; 38: 299-303.
27. Woodworth BA, Chandra RK, Joy MJ, Lee F, Schlosser RJ, Gillespie MB,. Randomized controlled trial of hyaluronic acid/carboxymethylcellulose dressing after endoscopic sinus Surgery. ORL J Otorhinolaryngol Relat Spec 2010; 72: 101-105.
28. Tankova T, Dakovska G, Koev D,. Zinc hyaluronate in the treatment of diabetic foot ulcers: a controlled randomized open-label study. Diabetol Croat 2001; 30: 93-96.
29. Cuevas FR, Méndez AAV, Andrade IC,. Zinc hylauronate effects on ulcers in diabetic patients. European Wound Management Assocation Journal Supplement; October 2009. Available at (accessed November 25, 2011).
30. Apelqvist J, Larsson J, Stenström A,. Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of DuoDerm and MeZinc. Br J Dermatol 1990; 123: 787-792.
31. Brandup F, Menné T, Agren MS, Strömberg HE, Holst R, Frisén M,. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm Venerol 1990; 70: 23-25.
32. Primavera G, Carrera M, Barardesca E,. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XCLAIR™), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol 2006; 25: 165-171. (Pubitemid 44410610)
33. Leonardi MC, Gariboldi S, Ivaldi GB, Ferrari A, Serafini F, Didier F,. A double-blind, randomized vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis. Eur J Dermatol 2008; 18: 317-321. (Pubitemid 351821237)
34. Wasiak J, Cleland H, Campbell F,. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev 2008; (4): CD002106. DOI: 10.1002/14651858.CD002106.pub3.
35. Palfreyman SSJ, Nelson EA, Lochiel R, Michaels JA,. Dressings for healing venous leg ulcers. Cochrane Database Syst Rev 2006; (3): CD001103. DOI: 10.1002/14651858.CD001103.pub2.
36. Nelson EA, Bradley MD,. Dressings and topical agents for arterial leg ulcers. Cochrane Database Syst Rev 2007; (1): CD001836. DOI: 10.1002/14651858.CD001836.pub2. (Pubitemid 351820431)
37. Taddeucci P, Pianigiani E, Colleta V, Torasso F, Andreassi A,. An evaluation of Hyalofill-F plus compression bandaging in the treatment of chronic venous ulcers. J Wound Care 2004; 13: 202-204.
38. Romanelli M, Dini V, Bertone M, Barbanera S, Brilli C,. OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J 2007; 4: 3-7.
39. Jüni P, Altman G, Egger M,. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-46. (Pubitemid 32682008)
40. Galasso U, Fiumanò F, Cloro L, Strati V,. L'uso dell'acido ialuronico nella terapia delle ulcere varicose degli arti inferiori. Minerva Chir 1978; 33: 1581-1596. (Pubitemid 9073772)
41. Passarini B, Tosti A, Fanti PA, Varotti C,. Effetto dell'acido ialuronico sul precesso riparitivo delle ulcere trofiche. Giornale Italiano di Dermatologia e Venereologia 1982; 117: 1-4.
42. Chen WYJ, Abatangelo G,. Functions of hyaluronan in wound repair. Wound Rep Reg 1999; 7: 79-89. (Pubitemid 29200045)
43. Neustadt D, Altman RD,. Intra-articular therapy. In:, Moskowitz RW, Altman RD, Buckwalter JA, Goldberg VM, Hochberg MC, editors. Osteoarthritis. Philadelphia, PA: Lippincott Williams and Wilkins, 2007: 287-301.
44. Presti D, Scott JE,. Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994; 12: 281-288. (Pubitemid 24350570)
45. Kvam BJ, Fragonas E, Degrassi A, Kvan C, Matulova M, Pollesello P, Zanetti F, Vittur F,. Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives and on the metabolism of articular chrondrocytes. Exp Cell Res 1995; 218: 79-86.
46. Wu SC, Crews RT, Armstrong DG,. The pivotal role of offloading in the management of neuropathic foot ulceration. Curr Diab Rep 2005; 5: 423-429. (Pubitemid 43020008)
47. Spencer SA,. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database Syst Rev 2000; (3): CD002302. DOI: 10.1002/14651858.CD002302.
48. Armstrong DG, Nguyen HC, Lavery LA, van, Schie CH, Boulton AJ, Harkless LB,. Off-loading the diabetic foot wound. Diabetes Care 2001; 24: 1019-1022.
49. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Armstrong DG, Harkless LB, Boulton AJ,. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001; 18: 133-138. (Pubitemid 32238959)
50. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA,. Risk factors for delayed healing of neuropathic diabetic foot ulcers. Arch Dermatol 2000; 136: 1531-1535. (Pubitemid 32009274)